CDK9 and pachyonychia congenita: We confirmed that CDK9 inhibitor doses that induce selective DNA damage also decrease RNA Pol II activity in PC, CRPC and normal cells by measuring MYC mRNA levels after 4 h treatment (Additional file 1: Fig. S5C).